483 Document: Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy, May 22, 2017

FDANews 483 Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy May 22 2017 top
Bryan L. McGuckin FDA Investigator Christopher D. Leach FDA Investigator

On May 22, 2017, the FDA inspected Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy's Roselle site. Explore the inspectional observations.